D-0619-2026 Class III Ongoing

Recalled by ANI Pharmaceuticals, Inc. — Baudette, MN

FDA drug recall D-0619-2026 was initiated by ANI Pharmaceuticals, Inc. on Jun 2, 2026 and is designated Class III. Reason for recall: Presence of foreign substance The recall status is ongoing. Affected quantity: 6564 bottles.

Recall details

Product Type
Drugs
Report Date
Jul 1, 2026
Initiation Date
Jun 2, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
6564 bottles

Product description

hydrOXYzine Hydrochloride Oral Solution, USP, 10 mg/5 mL, 473 mL (1 Pint), Rx only, Distributed by: ANI Pharmaceuticals, Inc., Baudette, MN 56623. NDC: 70954-912-10

Reason for recall

Presence of foreign substance

Distribution pattern

Nationwide in the USA

Code information

Lot S25133A

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0619-2026
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0619-2026. Report a data issue: hello@regdatalab.com.